Information for patients

Posted by: Admin-SG - Posted on:

North East and North Cumbria Integrated Care Board (NENC ICB) is commissioning a primary care-based service to provide this medicine to patients, which is anticipated to go-live from the 23June 2025.

Information for patients on new eligibility criteria for Tirzepatide (Mounjaro®) weight loss injections is available on the NHS England website. NHS England » Medicines for obesity and North East and North Cumbria ICB website Advice and support weight-loss drugs information for patients